GYRE THERAPEUTICS, INC.

Major Shareholding Notification • Feb 13, 2019

SC 13G 1 sc13g.htm

Field: Rule-Page

Field: /Rule-Page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. ______)*

CATALYST BIOSCIENCES, INC.

Field: Rule-Page

Field: /Rule-Page

(Name of Issuer)

COMMON STOCK, PAR $0.001

Field: Rule-Page

Field: /Rule-Page

(Title of Class of Securities)

14888D208

Field: Rule-Page

Field: /Rule-Page

(CUSIP Number)

ACUTA CAPITAL PARTNERS LLC, 1301 SHOREWAY ROAD, SUITE 350, BELMONT CA 94002

Field: Rule-Page

Field: /Rule-Page

(Name, Address and Telephone Number of Person

Authorized to Receive Notices and Communications)

December 31, 2018

Field: Rule-Page

Field: /Rule-Page

(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

[X] Rule 13d-1(b)

[ ] Rule 13d-1(c)

[ ] Rule 13d-1(d)

• The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1

Field: /Page

CUSIP No. 14888D208 13G Page 2 of 5 Pages

| 1. | NAMES
OF REPORTING PERSONS I.R.S.
IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) ACUTA
CAPITAL PARTNERS LLC 45-2817402 |
| --- | --- |
| 2. | CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a)
[ ] (b)
[ ] |
| 3. | SEC
USE ONLY |
| 4. | CITIZENSHIP
OR PLACE OF ORGANIZATION STATE
OF DELAWARE |

| NUMBER
OF SHARES BENEFICIALLY OWNED
BY EACH REPORTING PERSON
WITH | SOLE
VOTING POWER 0 |
| --- | --- |
| 6. | SHARED
VOTING POWER |
| 7. | SOLE
DISPOSITIVE POWER 0 |
| 8. | SHARED
DISPOSITIVE POWER |

| 9. | AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 |
| --- | --- |
| 10. | CHECK
IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES |
| 11. | PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 0% |
| 12. | TYPE
OF REPORTING PERSON IA |

Field: Page; Sequence: 2

Field: /Page

CUSIP No. 14888D208 13G Page 3 of 5 Pages

Item 1.

| (a) | Name
of Issuer CATALYST
BIOSCIENCES, INC. |
| --- | --- |
| (b) | Address
of Issuer’s Principal Executive Offices 260 LITTLEFIELD
AVENUE SOUTH
SAN FRANCISCO CA 94080 |

Item 2.

| (a) | Name
of Person Filing ACUTA
CAPITAL PARTNERS LLC |
| --- | --- |
| (b) | Address
of the Principal Office or, if none, residence 1301
SHOREWAY ROAD, SUITE 350, BELMONT,
CA, 94002 |
| (c) | Citizenship USA |
| (d) | Title
of Class of Securities COMMON
SHARES, PAR $0.001 |
| (e) | CUSIP
Number 14888D208 |

Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

| (a) | [ ] | Broker
or dealer registered under section 15 of the Act (15 U.S.C. 78o). |
| --- | --- | --- |
| (b) | [ ] | Bank
as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). |
| (c) | [ ] | Insurance
company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). |
| (d) | [ ] | Investment
company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). |
| (e) | [X] | An
investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); |
| (f) | [ ] | An
employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); |
| (g) | [ ] | A
parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G); |
| (h) | [ ] | A
savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); |
| (i) | [ ] | A
church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company
Act of 1940 (15 U.S.C. 80a-3); |
| (j) | [ ] | Group,
in accordance with §240.13d-1(b)(1)(ii)(J). |

Field: Page; Sequence: 3

Field: /Page

CUSIP No. 14888D208 13G Page 4 of 5 Pages

Item 4. Ownership.

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

| (a) | Amount
beneficially owned: 0 |
| --- | --- |
| (b) | Percent
of class: 0% |
| (c) | Number
of shares as to which the person has: |

| (i) | Sole
power to vote or to direct the vote 0 |
| --- | --- |
| (ii) | Shared
power to vote or to direct the vote 0 |
| (iii) | Sole
power to dispose or to direct the disposition of 0 |
| (iv) | Shared
power to dispose or to direct the disposition of 0 |

Item 5. Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [X].

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

Item 8. Identification and Classification of Members of the Group.

Item 9. Notice of Dissolution of Group.

Item 10. Certification.

| (a) | The
following certification shall be included if the statement is filed pursuant to §240.13d-1(b): |
| --- | --- |
| | By
signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are
held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing
or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as
a participant in any transaction having that purpose or effect. |
| (b) | The
following certification shall be included if the statement is filed pursuant to §240.13d-1(c): |
| | By
signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and
are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities
and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. |

Field: Page; Sequence: 5

Field: /Page

CUSIP No. 14888D208 13G Page 5 of 5 Pages

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

02/13/2019
Date
/s/
Manfred Yu
Signature
Manfred
Yu, CCO & COO
Name/Title

Field: Page; Sequence: 6

Field: /Page